Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$52.06 - $61.27 $6.17 Million - $7.27 Million
-118,586 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$44.23 - $57.5 $815,910 - $1.06 Million
-18,447 Reduced 13.46%
118,586 $6.12 Million
Q4 2020

Feb 02, 2021

BUY
$33.21 - $46.54 $280,059 - $392,471
8,433 Added 6.56%
137,033 $5.94 Million
Q3 2020

Nov 05, 2020

BUY
$33.87 - $55.93 $121,931 - $201,348
3,600 Added 2.88%
128,600 $4.5 Million
Q2 2020

Aug 12, 2020

BUY
$34.45 - $53.48 $65,455 - $101,612
1,900 Added 1.54%
125,000 $6.69 Million
Q1 2020

May 12, 2020

BUY
$31.52 - $53.81 $119,555 - $204,101
3,793 Added 3.18%
123,100 $4.37 Million
Q4 2019

Jan 27, 2020

BUY
$30.08 - $50.59 $989,842 - $1.66 Million
32,907 Added 38.09%
119,307 $5.7 Million
Q3 2019

Oct 31, 2019

BUY
$32.4 - $49.58 $813,240 - $1.24 Million
25,100 Added 40.95%
86,400 $2.8 Million
Q2 2019

Aug 15, 2019

SELL
$46.17 - $68.1 $41,553 - $61,289
-900 Reduced 1.45%
61,300 $3.06 Million
Q1 2019

May 03, 2019

SELL
$45.92 - $67.67 $45,920 - $67,670
-1,000 Reduced 1.58%
62,200 $4.2 Million
Q4 2018

Feb 08, 2019

SELL
$42.73 - $76.53 $650,222 - $1.16 Million
-15,217 Reduced 19.41%
63,200 $2.91 Million
Q3 2018

Nov 13, 2018

SELL
$71.67 - $91.95 $318,358 - $408,441
-4,442 Reduced 5.36%
78,417 $6.05 Million
Q2 2018

Aug 15, 2018

BUY
$73.22 - $99.55 $355,775 - $483,713
4,859 Added 6.23%
82,859 $6.98 Million
Q1 2018

May 11, 2018

SELL
$59.83 - $86.53 $227,354 - $328,814
-3,800 Reduced 4.65%
78,000 $6.38 Million
Q4 2017

Feb 06, 2018

BUY
$52.12 - $72.33 $2.38 Million - $3.31 Million
45,700 Added 126.59%
81,800 $4.68 Million
Q3 2017

Nov 15, 2017

BUY
$54.89 - $67.12 $1.98 Million - $2.42 Million
36,100
36,100 $2.41 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.26B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.